Medical Nutrition Market Size & Outlook, 2025-2033

Medical Nutrition Market Overview

The global medical nutrition market size was valued at USD 50.34 billion in 2024 and is projected to grow from USD 53.80 billion in 2025 to reach USD 91.54 billion by 2033, growing at a CAGR of 6.87% during the forecast period (2025–2033).

Key Market Indicators

• North America dominated the medical nutrition industry and accounted for a 33.12% share in 2024.
• Based on nutrition type, the protein segment held the largest share of 30.28% of the medical nutrition industry in 2024, owing to its crucial role in tissue repair, immune function, and muscle maintenance, especially in patients recovering from surgery, trauma, or chronic illness.
• Based on patient type, the infant nutrition segment is witnessing steady growth, driven by the need for specialized nutritional products that support early development and manage conditions like premature birth, low birth weight, and metabolic disorder.
• Based on the route of administration, the offline segment dominated the medical nutrition industry in 2024 due to its ease of use, cost-effectiveness, and high patient compliance.

Market Size & Forecast

• 2024 Market Size: USD 50.34 Billion
• 2033 Projected Market Size: USD 91.54 Billion
• CAGR (2025-2033): 6.87%
• North America: Largest market in 2024
• Asia Pacific: Fastest-growing region

The global medical nutrition market is experiencing significant growth driven by several interrelated factors. The surging prevalence of chronic diseases such as cancer, diabetes, and cardiovascular conditions is creating a consistent demand for specialized nutritional support to aid treatment and recovery. Simultaneously, the growing aging population worldwide is fueling the need for products tailored to age-related conditions like frailty, muscle loss, and cognitive decline.

Moreover, the shift toward preventive healthcare has heightened awareness regarding the role of nutrition in maintaining long-term health, encouraging the integration of medical nutrition into routine care. Additionally, technological advancements in clinical research are enabling the development of condition-specific formulations that improve patient outcomes and quality of life. Together, these drivers are transforming the global market from a supportive therapy into a critical component of healthcare, expanding its application across hospitals, home care settings, and outpatient clinics globally.

Market Trend

Emergence of E-Commerce and Direct-to-Consumer Channels

The global market is increasingly influenced by the growing demand for personalized nutrition. This trend is being driven by advancements in digital health technologies, genomic testing, and AI-powered analytics that allow for the customization of dietary plans based on an individual's genetic makeup, health status, and lifestyle. Personalized nutrition is gaining favor among both consumers and healthcare providers for its potential to improve health outcomes, especially in managing chronic diseases.

• For instance, in May 2025, AI health startup Superpower acquired Base, an at-home lab testing company specializing in dietary analysis. This acquisition fuels its ambitions to build a health "super app" offering personalized nutrition, sleep, and hormone optimization plans, reviewed by human experts, and positions the company deeper into the growing nutrition-as-medicine space.

This trend reflects a broader movement toward preventive and precision healthcare.

To get more insights about this report Download Free Sample Report

Market Driver

Rising Prevalence of Malnutrition in Hospitalized Patients

The global burden of hospital-related malnutrition continues to grow, significantly impacting patient recovery, hospital stays, and treatment outcomes. Malnutrition compromises immunity, delays wound healing, and increases susceptibility to infections, particularly among the elderly and chronically ill. Hospitals are now integrating clinical nutrition as a core aspect of patient care to counter these risks.

• For instance, a 2025 nationwide study in Türkiye screened 191,028 adult inpatients and found 11.6% were at risk of malnutrition upon admission. For patients over 65, this risk nearly doubled to 20.4%, and reached up to 30.2% in those above 80. Critically, ICU patients held the highest risk at 31.9%, followed by those in hematology/oncology (25.5%) and neurology (18.7%) departments.

These alarming figures depict the urgent need for standardized medical nutrition interventions in clinical settings.

Market Restraint

High Cost of These Products

The high cost of medical nutrition products remains a major restraint in the global market, especially in low- and middle-income countries. Specialized nutritional supplements designed for disease management, such as oncology or renal care formulas, are often priced significantly higher than regular food or general supplements. This creates affordability challenges for both patients and healthcare providers, limiting access and adherence to prescribed nutritional therapy.

Furthermore, the lack of reimbursement policies in many regions exacerbates the financial burden on patients. In developing economies, even public hospitals struggle to provide consistent supplies due to budget constraints. These factors collectively hinder widespread adoption and market penetration of medical nutrition solutions.

Market Opportunity

Government Support and Awareness Campaigns

Government-led initiatives and awareness programs play a pivotal role in expanding the global market, especially in emerging economies. These campaigns aim to address malnutrition, improve healthcare outcomes, and promote therapeutic nutrition across diverse populations. Health ministries and global organizations are increasingly funding programs focused on preventive and clinical nutrition, which are fueling demand for specialized medical nutrition products.

• For instance, in Nigeria, a multi-level advocacy campaign led by the Nutrition Society of Nigeria and federal health agencies launched "ThirdParty Advocacy Campaign (TPAC)" in early 2025, promoting food fortification and distributing therapeutic foods to vulnerable children along with nutrition education in communities.

Similar interventions in countries like India, Brazil, and Kenya have included free nutritional supplements in public health schemes. These government-backed efforts present significant opportunities for manufacturers to collaborate and expand their market footprint.

Regional Insights

The North American market is experiencing steady growth owing to increasing chronic disease prevalence and a robust healthcare infrastructure. High awareness of clinical nutrition, strong presence of key market players, and widespread insurance coverage for nutritional therapy drive adoption. Technological advancements in personalized and enteral nutrition delivery systems further support market expansion. Regulatory frameworks encouraging nutritional interventions in clinical care settings, along with a growing elderly population needing long-term care, are boosting demand. Expanding telehealth and digital prescription platforms are enhancing access to therapeutic nutrition products.

U.s. Medical Nutrition Market Trends

• The U.S. market is expanding rapidly owing to the high prevalence of chronic diseases and a strong healthcare infrastructure. According to the CDC, about 6 in 10 adults in the U.S. have a chronic disease, boosting demand for disease-specific nutrition. Companies like Abbott and Nestlé Health Science are leading players, offering enteral and parenteral nutrition for cancer, diabetes, and critical care patients across hospitals and home settings.
• Canada's medical nutrition market is driven by an aging population and increasing focus on patient recovery. With over 18% of Canadians aged 65 or older (StatCan, 2024), demand for elderly-targeted nutritional therapies is rising. Government-supported programs like Canada's Food Guide emphasize clinical nutrition. Companies such as B. Braun and Fresenius Kabi are actively partnering with healthcare providers to offer customized nutrition solutions in long-term care facilities and hospitals.

Asia-Pacific: Significantly Growing Region

The Asia Pacific region is witnessing rapid expansion in the global market owing to rising healthcare awareness, improving access to hospital care, and growing incidences of lifestyle-related diseases. Malnutrition rates among children and elderly populations remain significant, prompting a stronger demand for disease-targeted nutritional products. Economic growth is enhancing healthcare budgets, while emerging private healthcare sectors are adopting clinical nutrition more widely. Local production capabilities are improving, making products more affordable. The shift toward preventive healthcare and the expansion of outpatient care services are contributing to continued market penetration.

• China's medical nutrition market is witnessing robust growth driven by an aging population and a rising burden of chronic diseases. The Chinese government's "Healthy China 2030" initiative promotes clinical nutrition to prevent and manage non-communicable diseases. Companies like Nestlé Health Science and Baxter have expanded local operations to meet demand. Additionally, urban consumers are increasingly adopting enteral nutrition products for post-operative and elderly care.
• India's medical nutrition industry is expanding rapidly due to increasing awareness of hospital malnutrition and a growing middle-class population. The National Nutrition Mission (POSHAN Abhiyaan) is fostering nutritional awareness across demographics. Local players such as Dr. Reddy's and international brands like Abbott are offering specialized nutritional formulations. Hospitals are integrating nutritional therapy as part of standard care for oncology, ICU patients, and post-surgical recovery.

Europe: Substantial Potential for Growth

Europe's market is growing due to strong public health initiatives and stringent clinical nutrition guidelines. The region places high emphasis on nutritional support in post-surgical recovery, geriatrics, and oncology care. Government reimbursement policies for enteral and parenteral nutrition contribute to market uptake. Clinical research promoting nutrition therapy integration into standard care practices has further accelerated demand. Additionally, increasing healthcare expenditure and advanced hospital infrastructure support the consistent use of medical nutrition products, especially in intensive care units and long-term care facilities, thereby fostering sustained regional market growth.

• Germany's market for medical nutrition is thriving due to its advanced healthcare system and aging population. Hospitals widely adopt clinical nutrition for post-surgery recovery and chronic disease management. For instance, companies like Fresenius Kabi, headquartered in Germany, lead in enteral and parenteral nutrition solutions. Government-backed initiatives for elderly care and malnutrition screening programs are also accelerating market growth, especially in long-term care facilities and rehabilitation centers.
• The UK medical nutrition market is expanding due to NHS-supported programs targeting malnutrition in the elderly and cancer patients. Initiatives like the Malnutrition Universal Screening Tool (MUST) help healthcare providers identify nutritional risks early. Leading players such as Nutricia (Danone) are active in hospitals and home care services. Moreover, the growing demand for home-based enteral feeding and digital health consultations is enhancing accessibility to medical nutrition across rural and urban regions.

Market Segmentation

Nutrition Type Insights

The protein segment holds a significant share in the market due to its crucial role in tissue repair, immune function, and muscle maintenance, especially in patients recovering from surgery, trauma, or chronic illness. High-protein nutritional supplements are widely used in clinical nutrition to improve patient outcomes and support faster recovery, particularly in hospital and elderly care settings.

Patient Type Insights

The infant nutrition segment is driven by the need for specialized nutritional products that support early development and manage conditions like premature birth, low birth weight, and metabolic disorders. Medical-grade infant formulas and fortified products help address nutritional deficiencies and promote healthy growth, especially in neonatal intensive care units (NICUs) and pediatric care facilities.

Route of Administration Insights

The oral segment dominates the route of administration in this market due to its ease of use, cost-effectiveness, and high patient compliance. It includes ready-to-drink nutritional supplements, powders, and fortified foods designed for individuals who can swallow but require additional dietary support to meet their therapeutic needs, especially in outpatient and home care settings.

Application Insights

The cancer segment commands a substantial portion of the market, as patients undergoing chemotherapy or radiation often suffer from severe malnutrition, muscle wasting, and appetite loss. Specialized oncology nutrition helps maintain energy levels, strengthen immunity, and improve treatment tolerance, thereby enhancing overall quality of life and recovery prospects for cancer patients.

End-User Insights

Hospitals represent the largest end-user segment, owing to the widespread adoption of clinical nutrition for critical care, post-operative recovery, and chronic disease management. Medical nutrition is integral to patient treatment plans, particularly in intensive care units (ICUs) and surgical wards, where rapid nutritional intervention is essential to improve health outcomes and reduce hospital stays.

Company Market Share

Companies in the global market are focusing on expanding their product portfolios through research-driven innovation, targeting specific health conditions like oncology, diabetes, and critical care. They are also investing in clinical trials to demonstrate product efficacy, partnering with healthcare providers, and leveraging digital platforms for wider distribution. Additionally, efforts are being made to enhance affordability and accessibility in emerging markets, contributing to overall market expansion and competitive positioning.

Fresenius Kabi AG: Fresenius Kabi AG, founded in 1999 and headquartered in Bad Homburg, Germany, is a global specialist in infusion, transfusion, and clinical nutrition therapies, operating in over 100 countries with more than 43,000 employees and around €8 billion in annual sales. A pioneer in both enteral and parenteral nutrition, it offers comprehensive product lines including Fresubin® tube feeds, multi‑chamber bags, pumps, and disposables that support critically and chronically ill patients across hospital and home care settings

• In June 2025, Fresenius Kabi inaugurated its expanded Enteral Nutrition R&D Center in Gurugram, India. This state-of-the-art facility aims to enhance product innovation and foster collaboration across its global network, supporting the development of advanced clinical nutrition solutions tailored to regional and international healthcare needs.

List of key players in Medical Nutrition Market

1. Nestlé Health Science
2. Abbott Laboratories
3. Danone S.A.
4. Braun Melsungen AG
5. Fresenius Kabi AG
6. Baxter International Inc.
7. Mead Johnson Nutrition Company (Reckitt Benckiser Group)
8. Nutricia
9. Perrigo Company plc
10. GlaxoSmithKline plc (GSK)

To get more findings about this report Download Market Share

Recent Developments

• April 2025- Nestlé launched a targeted line of pre‑meal protein drinks using proprietary whey protein microgel technology. These are designed to support appetite suppression, blood sugar stabilization, and muscle preservation, especially for patients on GLP‑1 medications like Ozempic.
• April 2025- Arla has expanded its micellar‑casein (MCI) portfolio with Lacprodan MicelPure Medical, designed specifically for medical nutrition applications, supporting protein delivery in malnutrition and condition‑specific dietary needs. This aligns with a broader market push toward more palatable and clinically relevant protein formulations.
• March 2025- NotCo is set to introduce a botanical GLP‑1 booster powder that can be added to foods to potentially stimulate satiety and regulate appetite, offering a non-injectable, food-based alternative to pharmaceutical GLP‑1 therapies. The product is expected to hit shelves within the next year.